<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:09:13 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="这增加了科兴疫苗获批的机会，据信科兴已售出3亿多支疫苗，主要销往发展中国家。中国希望借此扩大卫生外交，并成为全球疫苗业务的主要参与者，提升在科学领域的声誉。"><meta id="uuid" name="uuid" content="62a70550c430db294d70379f30034fc9"><meta id="headline" name="headline" content="巴西称中国科兴疫苗有效率为78% - 世界经济观察报中文网"><meta id="byline" name="byline" content="黄瑞黎,ERNESTO LONDOÑO"><meta id="date" name="date" content="2021-01-08T02:31:03.000Z"><link rel="alternate" href="../index.html" hreflang="zh-Hans"><link rel="alternate" href="../zh-hant/index.html" hreflang="zh-Hant"><link rel="alternate" href="https://www.nytimes.com/2021/01/07/business/china-coronavirus-vaccine-sinovac.html" hreflang="en-us"><link rel="canonical" href="../index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:62a70550c430db294d70379f30034fc9"><meta name="lang" property="lang" content="zh-cmn-hans"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="巴西称中国科兴疫苗有效率为78% - 世界经济观察报中文网"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="巴西称中国科兴疫苗有效率为78%"><meta property="og:type" content="article"><meta property="og:url" content="../index.html"><meta property="og:description" content="这增加了科兴疫苗获批的机会，据信科兴已售出3亿多支疫苗，主要销往发展中国家。中国希望借此扩大卫生外交，并成为全球疫苗业务的主要参与者，提升在科学领域的声誉。"><meta property="og:site_name" content="世界经济观察报中文网"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2021-01-08T02:31:03.000Z"><meta property="fb:pages" content="354478527979178"><meta property="fb:app_id" content="1752616314982485"><meta property="og:image" content="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo/00china-vaccine-hfo-articleLarge.jpg"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="../index.html"><meta property="twitter:title" content="巴西称中国科兴疫苗有效率为78%"><meta property="twitter:description" content="这增加了科兴疫苗获批的机会，据信科兴已售出3亿多支疫苗，主要销往发展中国家。中国希望借此扩大卫生外交，并成为全球疫苗业务的主要参与者，提升在科学领域的声誉。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo/00china-vaccine-hfo-articleLarge.jpg"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20210108123656"><meta name="utime" content="20210108023103"><meta name="pdate" content="20210108"><meta name="dat" content="Jan. 08, 2021"><meta name="hdl" content="巴西称中国科兴疫苗有效率为78%"><meta name="byl" content="黄瑞黎,ERNESTO LONDOÑO"><meta name="lp" content="这增加了科兴疫苗获批的机会，据信科兴已售出3亿多支疫苗，主要销往发展中国家。中国希望借此扩大卫生外交，并成为全球疫苗业务的主要参与者，提升在科学领域的声誉。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>巴西称中国科兴疫苗有效率为78% - 世界经济观察报中文网</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的跟踪器设置",
     "headline": "我们使用 cookie 做什么？",
     "summary": '<p>我们利用cookies和类似的技术识别您的重复访问和偏好。我们还使用它们来衡量广告系列的效果，定位广告并分析和网站流量。更多关于cookies的信息（包括如何停用），<a id="JSCookiePolicyLink" href="https://www.nytimes.com/zh-hans/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">请查看我们的“Cookie政策”</a>。</p><p>自2020年7月20日起，我们将根据您在我们服务中所访问的内容类型向您显示我们认为与您的兴趣相关的广告。您可以<a href="https://www.nytimes.com/zh-hans/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反对</a>。希望了解更多信息，请参见我们的<a href="https://nytimes.com/zh-hans/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隐私政策</a>。</p><p>通过在此处点击“我接受”或者“X”，您将被视为同意使用cookies。您随时可以通过我们的Cookie政策来更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的跟踪器设置",
     "rejectButton": "拒绝所有",
     "lang": 'zh-hans',
     "trackerLink": "https://www.nytimes.com/zh-hans/privacy/cookie-policy",
 };
 var purrString = {
     "button": "请勿出售我的个人信息",
     "snackbar": "你的设置已经保存在此浏览器和设备上。如果你清除了 cookie，这些设置也会被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的个人信息",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": '<p>The New York Times Company does not sell personal information of its readers as the term “sell” is traditionally understood. But “sell” under the CCPA is broadly defined. It includes the sharing of personal information with third parties in exchange for something of value, even if no money changes hands. For example, sharing an advertising or device identifier to a third party may be considered a “sale” under the CCPA. </p><p>To the extent The New York Times Company “sells” your personal information (as the term “sell” is defined under the CCPA), you have the right to opt-out of that “sale” on a going-forward basis at any time. To exercise this right, click the “Do Not Sell My Personal Information” link in the footer of our website or under your “Account,” which you have already done. You can also submit a request to opt-out by emailing us at privacy@nytimes.com with the subject line “California Resident - Do Not Sell.”</p><p>Once you have opted out, you will see a change to “We No Longer Sell Your Personal Information.” If you have an account with certain Times Services (specifically nytimes.com, cooking.nytimes.com, nytimes.com/crosswords, the New York Times app, the New York Times Cooking app and the New York Times Crossword app) and are logged in, we will save your preference and honor your opt-out request across browsers and devices so long as you remain logged in. If you are not logged in, or do not have an account with any Times Services listed above, your opt-out of the “sale” of personal information will be specific to the browser or device from which you have clicked “Do Not Sell My Personal Information” and until you clear your cookies (or local storage in apps) on this browser or device. </p><p>If your browser or device is using a “do not track” setting, we will detect it and honor it on that specific browser or device only. If you wish to have a “do not track” experience across all of your browsers and devices, please make sure that all of your browsers and devices are set on “do not track.”</p><p>After you opt out of the “sale” of your personal information, we will no longer “sell” your personal information to third parties (except in an aggregated or de-identified manner so it is no longer personal information), but we will continue to share your personal information with our service providers, which process it on our behalf. Exercising your right to opt out of the “sale” of your personal information does not mean that you will stop seeing ads on our sites and apps. </p><p>To opt-out of interest-based advertising as much as technically possible, go to <a href="http://www.nytimes.com/privacy/cookie-policy#how-do-i-manage-trackers" target="_blank">“How Do I Manage Trackers”</a> in our Cookie Policy. To opt out of the “sale” of your personal information from participating companies, please visit the Digital Advertising Alliance <a href="https://optout.privacyrights.info/?c=1" target="_blank">website</a> or <a href="https://www.privacyrights.info/appchoices" target="_blank">apps</a>. We do not control these opt-out mechanisms and are not responsible for their operation.</p><p>You can designate someone else to make a request on your behalf. To protect your information, we will ask for a signed permission from you authorizing the other person to submit a request on your behalf. We will contact you to verify your identity before we respond to your authorized agent’s request.<p/><p>After 12 months, we may ask you if you want to opt into the “sale” of your personal information.</p><p>For further information, please refer to our <a href="http://www.nytimes.com/privacy/privacy-policy" target="_blank">Privacy Policy.</a></p>',
     "lang": 'zh-hans'
 };
 cbSectionName = "business";
 cbByline = "黄瑞黎,ERNESTO LONDOÑO";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" src="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">简繁中文</div><div class="setting-option"><a href="../index024e.html?changeLang=zh-hans" class="active">简体 </a><a href="../index27d8.html?changeLang=zh-hant">繁体</a></div><div class="setting-title">世界经济观察报 出版语言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英语)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙语)</a></li></ul><div class="setting-title">字体大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商业与经济</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="../index.html"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="javascript:;" class="active"><span class="setting-btn-text">中英双语</span> <span class="setting-btn-text-mobile">双语</span></a></li><li><a href="https://www.nytimes.com/2021/01/07/business/china-coronavirus-vaccine-sinovac.html" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E5%B7%B4%E8%A5%BF%E7%A7%B0%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%85%B4%E7%96%AB%E8%8B%97%E6%9C%89%E6%95%88%E7%8E%87%E4%B8%BA78%25&amp;url=https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" data-headline="%E5%B7%B4%E8%A5%BF%E7%A7%B0%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%85%B4%E7%96%AB%E8%8B%97%E6%9C%89%E6%95%88%E7%8E%87%E4%B8%BA78%25"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E5%B7%B4%E8%A5%BF%E7%A7%B0%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%85%B4%E7%96%AB%E8%8B%97%E6%9C%89%E6%95%88%E7%8E%87%E4%B8%BA78%25&amp;url=https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" style="display: none;"></div><script src="/d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/" data-headline="%E5%B7%B4%E8%A5%BF%E7%A7%B0%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%85%B4%E7%96%AB%E8%8B%97%E6%9C%89%E6%95%88%E7%8E%87%E4%B8%BA78%25"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content article-dual font-normal"><div class="article-header"><header><small></small><h1>巴西称中国科兴疫苗有效率为78%</h1><h1 class="en-title">A Second Chinese Coronavirus Vaccine Is Said to Be Effective</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>黄瑞黎, ERNESTO LONDOÑO</address><time pudate="2021-01-08 02:31:03" datetime="2021-01-08 02:31:03">2021年1月8日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo/00china-vaccine-hfo-master1050.jpg" width="1050" height="700" alt="在北京等待接受新冠病毒检测的民众。中国已经着眼于向发展中国家提供这种病毒的疫苗。"><figcaption><span>在北京等待接受新冠病毒检测的民众。中国已经着眼于向发展中国家提供这种病毒的疫苗。</span> <cite>Noel Celis/Agence France-Presse — Getty Images</cite></figcaption></figure><div class="row"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Brazilian officials said Thursday that a coronavirus vaccine made by a Chinese company was effective, bolstering the chances of approval for a second Chinese inoculation that could be rolled out in much of the developing world.</div></div><div class="col-lg-6"><div class="article-paragraph">巴西官员周四表示，一家中国公司生产的新冠病毒疫苗是有效的，这增加了第二种中国疫苗获批的机会，它可能会在很多发展中国家推广。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Officials in the state of São Paulo, where a prominent medical research institute carried out a large study of the vaccine made by the Beijing-based Sinovac, said the inoculation had an efficacy rate of 78 percent.</div></div><div class="col-lg-6"><div class="article-paragraph">圣保罗州的官员表示，该疫苗的有效率为78%。该州一家著名医学研究机构对这种由北京科兴生物制造的疫苗进行了大规模研究。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The vaccine prevented all participants from developing serious and mild complications from the virus, officials said, calling it a highly effective preventive tool.</div></div><div class="col-lg-6"><div class="article-paragraph">官员们说，该疫苗预防了所有参与者出现因该病毒产生的重症和轻症，并称其为一种非常有效的预防工具。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In anticipation of approval, the vaccine, CoronaVac, has already been shipped around the world as countries prepare for mass inoculation campaigns. Sinovac has sold more than 300 million doses, mostly to low- and middle-income countries, accounting for about half of the total doses that China says vaccine makers were capable of producing in 2020, based on an analysis of company statements and media reports.</div></div><div class="col-lg-6"><div class="article-paragraph">随着各国准备开展大规模接种运动，预计将获批的新冠病毒疫苗CoronaVac已经运往世界各地。根据对公司声明和媒体报道的分析，科兴已售出3亿多支疫苗，主要销往中低收入国家，占中国所称疫苗制造商2020年产能总量的一半左右。</div></div></div></div><div class="article-body-aside col-lg-3"><div id="subscribe_cont" style="margin: 0 auto;" class="container"></div></div></div><div class="big_ad" id="medium-rectangle-ad-0" data-target="{&quot;pos&quot;:&quot;mid1&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">China has set its sights on <a href="https://www.nytimes.com/2020/09/11/business/china-vaccine-diplomacy.html">supplying the developing world</a> with a Covid-19 vaccine, in a push to position itself as a leader in health diplomacy after its failures in the <a href="https://www.nytimes.com/2020/12/30/world/asia/china-coronavirus.html">early days of the outbreak</a>. It also wants to burnish its credentials in science by becoming a major player in the global vaccine business.</div></div><div class="col-lg-6"><div class="article-paragraph">中国已着眼于<a href="../../../20200911/china-vaccine-diplomacy/index.html">向发展中国家提供新冠疫苗</a>，在经历了<a href="#https://cn.nytimes.com/china/20201230/china-coronavirus/">疫情暴发初期的失败</a>后，此举旨在推动中国成为卫生外交的领导者。它还希望成为全球疫苗业务的主要参与者，从而提升自己在科学领域的声誉。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Even without the regulatory greenlight, China has embarked on an <a href="https://www.nytimes.com/2020/12/29/business/china-coronavirus-vaccine.html">aggressive vaccination drive at home</a>, with the goal of inoculating 50 million people by the middle of next month. Beijing has also developed an overseas distribution plan for exports, directing airlines to stock up on refrigerators and dry ice.</div></div><div class="col-lg-6"><div class="article-paragraph">即使监管部门尚未批准，中国<a href="../../../20201230/china-coronavirus-vaccine/index.html">已经开始在国内积极开展疫苗接种运动</a>，目标是到下个月中旬让5000万人接种疫苗。北京还制定了海外出口分销计划，指示航空公司储备冰箱和干冰。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo2/merlin_181581558_4e30eb30-5140-4a7f-8e46-f1a87230e00e-master1050.jpg" alt="在巴西圣保罗的布坦坦研究所，科兴的新冠病毒疫苗装配线。" data-src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo2/merlin_181581558_4e30eb30-5140-4a7f-8e46-f1a87230e00e-master1050.jpg"></div><figcaption><span>在巴西圣保罗的布坦坦研究所，科兴的新冠病毒疫苗装配线。</span> <cite>Amanda Perobelli/Reuters</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">China is filling a void in poorer nations left by Western competitors. The United States is mainly focused on working through the <a href="https://www.nytimes.com/2020/12/31/health/vaccine-distribution-delays.html" title="Link: https://www.nytimes.com/2020/12/31/health/vaccine-distribution-delays.html">chaos of distributing its vaccines </a>at home. The European Union and other rich countries have <a href="https://www.nytimes.com/2020/12/15/us/coronavirus-vaccine-doses-reserved.html">bought many of the doses </a>supplied by the American drugmakers Pfizer and Moderna.</div></div><div class="col-lg-6"><div class="article-paragraph">中国正在填补西方竞争对手给贫穷国家留下的空白。美国目前主要致力于<a href="https://www.nytimes.com/2020/12/31/health/vaccine-distribution-delays.html">解决国内疫苗分发的混乱局面</a>。<a href="https://www.nytimes.com/2020/12/15/us/coronavirus-vaccine-doses-reserved.html">欧盟和其他富裕国家采购了大量</a>由美国制药商辉瑞(Pfizer)和莫德纳(Moderna)提供的疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“The Chinese have been eager to get out in front, aware of the gap and the hoarding and pre-purchase of so many billions of doses by the Western governments that is leaving so many countries high and dry,” said<strong> </strong>J. Stephen Morrison, director of the global health policy center at the Center for Strategic and International Studies.</div></div><div class="col-lg-6"><div class="article-paragraph">“中国一直急于走在前面，他们意识到这个缺口，也意识到西方政府会囤积和预购数十亿剂疫苗，让其他国家陷于困境，”战略与国际研究中心全球卫生政策中心主任J·史蒂芬·莫里森(J. Stephen Morrison)说。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“It will become a tool in their diplomatic alliances, and it will give them some measure of prestige and standing with countries that choose to make use of them,” he added.</div></div><div class="col-lg-6"><div class="article-paragraph">“这将成为他们外交联盟中的一种工具，将使他们在选择使用这些工具的国家中获得一定程度的威望和地位，”他还说。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Unlike players from the United States, Chinese vaccine makers had to think globally almost from the start. The companies had to <a href="https://www.nytimes.com/2020/07/16/business/china-vaccine-coronavirus.html">go abroad to test the efficacy of their vaccines</a> because the outbreak had been largely stamped out in China.</div></div><div class="col-lg-6"><div class="article-paragraph">与美国制造商不同，中国疫苗制造商几乎从一开始就必须考虑全球问题。<a href="../../../20200717/china-vaccine-coronavirus/index.html">它们只能到国外测试其疫苗的有效性</a>，因为疫情在中国已基本被扑灭。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-1" data-target="{&quot;pos&quot;:&quot;mid2&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In recent months, Chinese companies have signed agreements with at least 15 countries and regions, providing early access to doses.<strong> </strong>Their vaccines have been rolled out in the United Arab Emirates and Bahrain after being approved for emergency use.</div></div><div class="col-lg-6"><div class="article-paragraph">近几个月来，中国企业已与至少15个国家和地区签署协议，提供及早接种疫苗的机会。他们的疫苗已在阿拉伯联合酋长国和巴林获准紧急使用。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Many of their early customers were the governments that cooperated on the late-stage, Phase 3 trials. Brazil has roughly 10.8 million doses of the vaccine on hand and intends to start producing it locally, and Indonesia and Turkey have both received shipments of Sinovac vaccines. Sinovac has said it is able to produce 600 million doses this year.</div></div><div class="col-lg-6"><div class="article-paragraph">他们的许多早期客户是在后期阶段，也就是三期试验阶段中合作的政府。巴西现有约1080万剂疫苗，并打算开始在当地生产，印度尼西亚和土耳其都收到了科兴的疫苗。科兴表示，今年有能力生产6亿剂疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">These deals could help vaccine makers <a href="https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html" title="Link: https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html">shake off the industry’s tarnished reputation</a> after a series of quality and corruption scandals. For decades, Chinese vaccine makers focused only on serving their domestic market. Only five Chinese vaccines have been preapproved for export by the World Health Organization — one of them is a hepatitis A shot made by Sinovac.</div></div><div class="col-lg-6"><div class="article-paragraph">这些交易可以帮助疫苗制造商<a href="../../../20200506/coronavirus-china-vaccine/index.html">摆脱该行业在一系列质量和腐败丑闻后受到玷污的声誉</a>。几十年来，中国疫苗制造商只专注于服务国内市场。只有五种中国疫苗获得世界卫生组织的出口预批准——其中一种是中国科兴生产的甲型肝炎疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The results in Brazil are closely watched by regulators in other countries that are conducting trials for the Sinovac vaccine because it had the biggest number of volunteers, at 12,476. Turkey announced on Dec. 24 that the <a href="https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html">vaccine had an efficacy rate of 91.25 percent</a>, but it was based on preliminary results from a small clinical trial. The scientists who ran the trial discussed the results at a news conference, but they did not provide the data online in written form.</div></div><div class="col-lg-6"><div class="article-paragraph">正在进行科兴疫苗试验的其他国家监管机构都在密切关注巴西的结果，因为该国的志愿者人数最多，达到12476人。土耳其12月24日宣布，<a href="https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html">该疫苗的有效率为91.25%</a>，但这是建立在一个小型临床试验的初步结果基础上。主持该试验的科学家在新闻发布会上对结果进行了讨论，但没有以书面形式在网上提供数据。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The Chinese government said on Dec. 31 that it had <a href="https://www.nytimes.com/2020/12/30/business/china-vaccine.html">approved another coronavirus vaccine</a> made by the state-owned company Sinopharm. Sinopharm had announced that its Phase 3 trials showed that its vaccine had an efficacy rate of 79.34 percent, but it did not provide any further trial data, making it impossible for outside experts to evaluate the claim.</div></div><div class="col-lg-6"><div class="article-paragraph">12月31日，中国政府表示，<a href="../../../20201230/china-vaccine/index.html">已批准国有企业国药集团生产的另一种新冠病毒疫苗</a>。国药集团曾宣布，三期试验表明其疫苗有效率为79.34%，但没有提供任何进一步的试验数据，因此外部专家无法对这一说法进行评估。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Dimas Covas, the director of Butantan Institute, which carried out the study, declined to provide detailed data about the vaccine study, including the number of people who contracted the virus broken down by placebo and vaccine volunteers.</div></div><div class="col-lg-6"><div class="article-paragraph">开展这项研究的巴西布坦坦研究所(Butantan Institute)所长迪马斯·科瓦斯(Dimas Covas)拒绝提供有关疫苗研究的详细数据，包括按安慰剂和疫苗志愿者分列的感染病毒人数。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-2" data-target="{&quot;pos&quot;:&quot;mid3&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In other countries, the vaccine was tested on ordinary people, but Dr. Covas said the Brazilian CoronaVac study relied solely on medical professionals, who were at higher risk of getting the virus than the general population.</div></div><div class="col-lg-6"><div class="article-paragraph">在其他国家，疫苗是在普通人身上进行测试，但科瓦斯表示，巴西的新冠病毒研究完全依赖医疗专业人员，他们感染病毒的风险比普通人更高。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“The vaccine was submitted to a hard test,” he said, adding that none of the test volunteers developed serious or moderate cases of Covid-19 or required hospitalization.</div></div><div class="col-lg-6"><div class="article-paragraph">他说：“该疫苗经过了严格的测试。”他还说，测试志愿者中没有人出现新冠重症或轻度病例，也没有人需要住院治疗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Officials in São Paulo said they were hopeful that Brazil’s health regulatory agency would approve emergency use of the vaccine within days. The country hit a grim milestone on Thursday: 200,000 deaths from the virus.</div></div><div class="col-lg-6"><div class="article-paragraph">圣保罗官员称，他们希望巴西卫生管理机构能在几天内批准紧急使用该疫苗。巴西在周四迎来了一个严峻的里程碑：新冠死亡人数达到20万。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">If approval is granted, officials said, Brazil could produce up to one million doses of the vaccine per day.</div></div><div class="col-lg-6"><div class="article-paragraph">官员们表示，如果获得批准，巴西每天可以生产多达100万剂疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Like the Sinopharm vaccine, CoronaVac is made with a traditional technology that uses an inactivated virus to provoke the body’s immune system to produce antibodies.</div></div><div class="col-lg-6"><div class="article-paragraph">跟国药集团的疫苗一样，CoronaVac也是采用一种传统技术制成的，使用灭活病毒刺激人体免疫系统产生抗体。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">These vaccines tend to have weaker efficacy rates, but they can be kept at refrigerated temperatures, making transportation and storage easier. Such characteristics are especially important for developing countries that may not have the infrastructure to maintain the frozen vaccines made by Pfizer and Moderna. Sinovac’s chief executive, Yin Weidong, called the inactivated technology “the best” one for the vaccine.</div></div><div class="col-lg-6"><div class="article-paragraph">这种疫苗的效力往往会低一些，但可以在冷藏温度下保存，使运输和储存容易得多。这些特性对发展中国家尤其重要，因其可能没有维持辉瑞和莫德纳生产的冷冻疫苗有效性的基础设施。科兴董事长尹卫东称，用灭活技术制作疫苗是“最好的”。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo3/00china-vaccine-hfo3-master1050.jpg" alt="在接受新冠疫苗接种前填写同意书的北京民众。中国设定的目标是到下个月中旬为5000万人接种疫苗。" data-src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo3/00china-vaccine-hfo3-master1050.jpg"></div><figcaption><span>在接受新冠疫苗接种前填写同意书的北京民众。中国设定的目标是到下个月中旬为5000万人接种疫苗。</span> <cite>Chen Zhonghao/Xinhua, via Associated Press</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Even before the pandemic, Sinovac’s reputation was well established within the biotech world. In 2003, it was the first company in the world to develop an experimental vaccine for another coronavirus outbreak — severe acute respiratory syndrome, or SARS.</div></div><div class="col-lg-6"><div class="article-paragraph">即便在新冠疫情之前，科兴在生物技术界就已经树立起良好的声誉。2003年，该公司成为世界上第一家为另一场冠状病毒疫情SARS（严重急性呼吸系统综合征）研发实验性疫苗的企业。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The company started testing it on humans but had to scrap further trials after the outbreak ended. But the experience proved fortuitous.</div></div><div class="col-lg-6"><div class="article-paragraph">该公司开始对人体进行试验，但在疫情结束后不得不取消了进一步的试验。不过，那次经历并非毫无意义。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-3" data-target="{&quot;pos&quot;:&quot;mid4&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Sinovac began work on a Covid-19 vaccine soon after a top Chinese epidemiologist disclosed on national television in late January that the coronavirus in Wuhan was being transmitted between humans. Scientists at the company canceled their Lunar New Year vacations and set to work on Operation Coronavirus.</div></div><div class="col-lg-6"><div class="article-paragraph">去年1月下旬，中国一位顶级流行病学家在国家电视台上披露，武汉的新冠病毒正在人传人，此后不久，科兴就开始研发新冠疫苗。该公司的科学家取消了春节假期，着手开展了“克冠行动”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Mr. Yin, 56, started his career as a doctor at the local disease and control center in the northern city of Tangshan. He was troubled by the scourge of hepatitis A and began wondering how he could make a vaccine to curb the disease.</div></div><div class="col-lg-6"><div class="article-paragraph">现年56岁的尹卫东的职业生涯始于北方城市唐山的疾病控制中心。甲肝的危害令其困扰，他开始思索如何才能造出疫苗来控制这种疾病。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In 1985, Mr. Yin, then 21, was the first to isolate the hepatitis A virus, and in 2001, he founded Sinovac Biotech.</div></div><div class="col-lg-6"><div class="article-paragraph">1985年，21岁的尹卫东成为首个分离出甲型肝炎病毒的人，2001年，他创立了科兴生物技术公司。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Along the way, Sinovac has been caught up in the industry’s bad practices. From 2002 to 2011, Mr. Yin paid $77,000 to a senior Chinese drug regulator, Yin Hongzhang, and his wife to approve his vaccines, according to a 2018 filing to the Securities and Exchange Commission, citing court documents.</div></div><div class="col-lg-6"><div class="article-paragraph">一路走来，科兴经常陷入行业的不良行为丑闻。根据2018年提交给美国证券交易委员会(Securities and Exchange Commission)的一份援引法庭记录的文件称，2002年到2011年，尹卫东向中国药品监管高级官员尹红章夫妇支付了逾50万元，以批准他的疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The regulator was jailed in 2017 for taking bribes from company executives, including the head of <a href="https://www.nytimes.com/2020/12/07/business/china-vaccine-astrazeneca.html">another vaccine company that has joined forces with AstraZeneca to make a Covid-19 vaccine.</a> The executives did not face scrutiny.</div></div><div class="col-lg-6"><div class="article-paragraph">该官员于2017年因收受公司高管贿赂入狱，行贿者还包括另一家疫苗公司的负责人，<a href="../../../20201207/china-vaccine-astrazeneca/index.html">该公司正与阿斯利康(AstraZeneca)联手生产新冠疫苗</a>。这些高管并未受到审查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">A Sinovac spokesman, Pearson Liu, said the incidents happened more than 10 years ago, adding that “neither Mr. Yin nor the company have been accused of any wrongdoing by any government authority on the allegations.”</div></div><div class="col-lg-6"><div class="article-paragraph">科兴发言人刘沛诚表示，这些事情发生在10多年前，并补充说，“政府当局未用这些罪名指控尹卫东或本公司有任何不当行为。”</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-4" data-target="{&quot;pos&quot;:&quot;mid5&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Sinovac’s key shareholders tried to use the bribery case involving Mr. Yin to oust him from his company. The messy battle culminated in the firm’s electricity supply being cut off by representatives of a key shareholder and a temporary halt to the supply of hepatitis A vaccines in China.</div></div><div class="col-lg-6"><div class="article-paragraph">科兴的主要股东曾试图利用尹卫东的行贿案将他排挤出公司。这场混乱的斗争最终导致该公司的电力供应被一位主要股东的代表切断，使中国甲型肝炎疫苗供应一度暂停。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Through it all, Mr. Yin has emerged unscathed, creating a corporate front-runner in China’s Covid-19 vaccine outreach efforts.</div></div><div class="col-lg-6"><div class="article-paragraph">在经历这一切之后，尹卫东的地位并未被动摇，还将科兴打造成为中国新冠疫苗推广的领军者。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo4/00china-vaccine-hfo4-master1050.jpg" alt="科兴为生产新冠疫苗而在北京建造的工厂。科兴已经售出了超过3亿剂疫苗，主要销往低收入和中等收入国家。" data-src="../../../../../static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo4/00china-vaccine-hfo4-master1050.jpg"></div><figcaption><span>科兴为生产新冠疫苗而在北京建造的工厂。科兴已经售出了超过3亿剂疫苗，主要销往低收入和中等收入国家。</span> <cite>Wang Zhao/Agence France-Presse — Getty Images</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">After promising early-stage trials, Sinovac determined that it would need help from a research institute in a place with an active outbreak. Brazil has the third-highest number of Covid-19 infections in the world after India and the United States, at 7.8 million cases, allowing Sinovac to <a href="https://www.nytimes.com/2020/08/15/world/americas/brazil-coronavirus-vaccine.html" title="Link: https://www.nytimes.com/2020/08/15/world/americas/brazil-coronavirus-vaccine.html">test much faster for the efficacy of its vaccine.</a></div></div><div class="col-lg-6"><div class="article-paragraph">在承诺进行早期试验后，科兴认定自己需要疫情活跃地区的一家研究机构的帮助。巴西的新冠感染病例数量居世界第三，仅次于印度和美国，有780万例，这使得科兴能<a href="https://www.nytimes.com/2020/08/15/world/americas/brazil-coronavirus-vaccine.html">更快地测试其疫苗的效力</a>。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The Butantan Institute in Brazil looked like an ideal partner. Both companies had developed a relationship that had started before the pandemic, said Dr. Covas, the director. The institute was also well versed in the technology that Sinovac was using.</div></div><div class="col-lg-6"><div class="article-paragraph">巴西布坦坦研究所看起来是个理想的合作伙伴。所长科瓦斯表示，双方早在疫情开始前就有合作关系。该研究所也精通于科兴正在使用的技术。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“We had common interests and, especially, the capacity to do this very quickly,” Dr. Covas said in an interview.</div></div><div class="col-lg-6"><div class="article-paragraph">“我们有共同利益，特别是也都有能力迅速完成这项工作，”科瓦斯在接受采访时表示。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In going abroad, Sinovac has been forced to navigate political minefields.</div></div><div class="col-lg-6"><div class="article-paragraph">在走出国门的过程中，科兴被迫穿越了政治雷区。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The company’s website was defaced by hackers from Turkey in recent weeks. The hackers put up the flag of East Turkestan, an emblem banned in China and generally used as a symbol of independence for the Uighurs, a Turkic Muslim minority group.</div></div><div class="col-lg-6"><div class="article-paragraph">最近几周，该公司的网站遭到了土耳其黑客的破坏。黑客们放上了东突厥斯坦的旗帜，这是中国禁止使用的标志，通常被用做突厥穆斯林少数民族维吾尔人的独立象征。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Its clinical trial has been <a href="https://www.nytimes.com/2020/12/14/world/americas/brazil-coronavirus-vaccine.html" title="Link: https://www.nytimes.com/2020/12/14/world/americas/brazil-coronavirus-vaccine.html">criticized by supporters of President Jair Bolsonaro</a>, who has rejected <a rel="noopener noreferrer" target="_blank" href="https://www.reuters.com/article/health-coronavirus-brazil/exclusive-brazil-will-have-a-covid-19-vaccine-by-june-2021-says-regulator-idUSL1N2HK30V" title="Link: https://www.reuters.com/article/health-coronavirus-brazil/exclusive-brazil-will-have-a-covid-19-vaccine-by-june-2021-says-regulator-idUSL1N2HK30V">his health ministry’s plan</a> to buy 46 million doses. In November, the trial was <a href="https://www.nytimes.com/2020/11/10/world/asia/brazil-china-vaccine-covid19.html">briefly suspended</a> after the death of a participant, a regulatory move that Mr. Bolsonaro — who has blamed China for the pandemic — hailed as a victory. The trial was <a href="https://www.nytimes.com/2020/11/11/world/brazil-resumes-chinese-vaccine-trial-after-a-brief-suspension-following-the-death-of-a-volunteer.html">resumed</a> after the health authority ruled that the death had been unrelated to the vaccine.</div></div><div class="col-lg-6"><div class="article-paragraph">该公司的临床试验受到了<a href="https://www.nytimes.com/2020/12/14/world/americas/brazil-coronavirus-vaccine.html">雅伊尔·博尔索纳罗(Jair Bolsonaro)总统支持者的批评</a>，博尔索纳罗还拒绝了<a rel="noopener noreferrer" target="_blank" href="https://www.reuters.com/article/health-coronavirus-brazil/exclusive-brazil-will-have-a-covid-19-vaccine-by-june-2021-says-regulator-idUSL1N2HK30V">该国卫生部</a>购买4600万剂疫苗的方案。去年11月，在一名参与者死亡后，试验被<a href="#https://cn.nytimes.com/world/20201111/brazil-china-vaccine-covid19/">暂停</a>，这一监管举措曾被博尔索纳罗称为一场胜利，他将疫情归咎于中国。但在卫生当局裁定死亡与疫苗无关后，试验又<a href="https://www.nytimes.com/2020/11/11/world/brazil-resumes-chinese-vaccine-trial-after-a-brief-suspension-following-the-death-of-a-volunteer.html" title="Link: https://www.nytimes.com/2020/11/11/world/brazil-resumes-chinese-vaccine-trial-after-a-brief-suspension-following-the-death-of-a-volunteer.html">恢复</a>了。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">It is unclear whether the Sinovac vaccines will even be used throughout Brazil. João Doria, a rival of Mr. Bolsonaro’s and the governor of the State of São Paulo, which has run the trials for Sinovac, has negotiated directly with the Chinese company for vaccine doses. He has announced that his state intends to start vaccinating people in late January, subject to regulatory approval. It’s the only state in the country to buy the Sinovac vaccine.</div></div><div class="col-lg-6"><div class="article-paragraph">尚不清楚科兴疫苗是否会在巴西全境使用。博尔索纳罗的竞争对手、为科兴进行试验的圣保罗州州长若昂·多利亚(João Doria)与该中国公司就疫苗剂量进行了直接谈判。他宣布，如果得到监管部门批准，该州预计在1月底开始接种疫苗。这是巴西唯一一个购买科兴疫苗的州。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">After the announcement on Thursday, Brazil’s health minister, Eduardo Pazuello, told reporters that the federal government intended to purchase 100 million doses of CoronaVac.</div></div><div class="col-lg-6"><div class="article-paragraph">周四宣布这一消息后，巴西卫生部长爱德华多·帕祖埃洛(Eduardo Pazuello)对记者表示，联邦政府准备购买一亿剂CoronaVac疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“This vaccine will save millions of people,” Mr. Doria said Thursday at a news conference. “Today is a day of hope.”</div></div><div class="col-lg-6"><div class="article-paragraph">“这种疫苗将拯救无数人，”多利亚在周四的新闻发布会上说。“今天是充满希望的一天。”</div></div></div></div><div class="article-body-aside col-lg-3"></div></div></section></div><div class="col-lg-12 row author-info-container"><footer class="author-info"><p>Mariana Simões和Letícia Casado对本文有报道贡献。Elsie Chen对本文有研究贡献。</p><p>黄瑞黎(Sui-Lee Wee)是《世界经济观察报》北京分社记者。她报道中国近十年，关注社会议题、性别、基因监测、医疗保健以及人口和经济的交叉议题。欢迎在Twitter上关注她 <a rel="nofollow" target="_blank" href="https://twitter.com/suilee">@suilee</a>。</p><p>Ernesto Londoño是《世界经济观察报》巴西分社社长，常驻里约热内卢。他此前曾担任社论撰稿人。在2014年加入时报之前，他供职于《华盛顿邮报》。欢迎在<a rel="nofollow" target="_blank" href="https://twitter.com/londonoe">Twitter</a>和<a rel="nofollow" target="_blank" href="https://www.facebook.com/londono">Facebook</a>上关注他。</p><p>翻译：世界经济观察报中文网</p><p><a rel="nofollow" target="_blank" href="http://www.nytimes.com/2020/12/30/business/china-vaccine.html">点击查看本文英文版。</a></p></footer></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 dual-refer-cont"><div class="related-cont"><h4>相关报道</h4><ul class="refer-list"><li class="link-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/topic/20200122/wuhan-coronavirus-pneumonia-topic/" title=""><div><h3 class="refer-list-headline">专题：聚焦新型冠状病毒疫情</h3></div></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20201229/sinovac-covid-19-vaccine/" title="中国科兴新冠疫苗的作用原理"><div><h3 class="refer-list-headline">中国科兴新冠疫苗的作用原理</h3><p class="refer-pubdate">2020年12月29日</p></div><img alt="中国科兴新冠疫苗的作用原理" src="../../../../../static01.nyt.com/images/2020/12/28/multimedia/c29sinovac-08/c29sinovac-08-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20201230/china-coronavirus-vaccine/index.html" title="中国距离大规模接种疫苗还有多远"><div><h3 class="refer-list-headline">中国距离大规模接种疫苗还有多远</h3><p class="refer-pubdate">2020年12月30日</p></div><img alt="中国距离大规模接种疫苗还有多远" src="../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-3/00china-vaccine-3-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20201230/china-vaccine/index.html" title="中国批准国药集团新冠疫苗上市"><div><h3 class="refer-list-headline">中国批准国药集团新冠疫苗上市</h3><p class="refer-pubdate">2020年12月30日</p></div><img alt="中国批准国药集团新冠疫苗上市" src="../../../../../static01.nyt.com/images/2020/12/09/business/00china-vaccine-HFO3/merlin_180960321_1e42b286-fd66-495d-97fb-d75d4a9479be-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20201207/china-vaccine-astrazeneca/index.html" title="中国“疫苗之王”：成功幕布下的丑闻"><div><h3 class="refer-list-headline">中国“疫苗之王”：成功幕布下的丑闻</h3><p class="refer-pubdate">2020年12月7日</p></div><img alt="中国“疫苗之王”：成功幕布下的丑闻" src="../../../../../static01.nyt.com/images/2020/10/05/business/00china-vaccine-2/00china-vaccine-2-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20200911/china-vaccine-diplomacy/index.html" title="中国在全球推行新冠疫苗外交"><div><h3 class="refer-list-headline">中国在全球推行新冠疫苗外交</h3><p class="refer-pubdate">2020年9月11日</p></div><img alt="中国在全球推行新冠疫苗外交" src="../../../../../static01.nyt.com/images/2020/09/03/world/00vaccine-diplomacy-5/00vaccine-diplomacy-5-thumbLarge.jpg" width="75" height="75"></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受欢迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>战棋推演报告称台湾半导体工厂停产可能引发中美冲突</h4><img alt="战棋推演报告称台湾半导体工厂停产可能引发中美冲突" src="../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“巴铁”军方为什么想与中国保持距离？</h4><img alt="“巴铁”军方为什么想与中国保持距离？" src="../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220128/china-fight-club-ending/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>《搏击俱乐部》结局遭篡改，中国审查制度再掀争议</h4><img alt="《搏击俱乐部》结局遭篡改，中国审查制度再掀争议" src="../../../../../static01.nyt.com/images/2022/01/27/multimedia/27xp-china-fightclub/27xp-china-fightclub-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中国追求“清零”将把国家置于灾难之中</h4><img alt="中国追求“清零”将把国家置于灾难之中" src="../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声</h4><img alt="澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声" src="../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220128/selective-high-schools-brooklyn-tech/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>作为亚裔学生就读纽约精英高中，是一种什么样的体验</h4><img alt="作为亚裔学生就读纽约精英高中，是一种什么样的体验" src="../../../../../static01.nyt.com/images/2022/01/17/us/17schools-selective1/merlin_200009688_449611ef-4c11-43d4-a6f2-e74b0066acdf-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>我们可能活在模拟现实中，人类应该多担忧这件事？</h4><img alt="我们可能活在模拟现实中，人类应该多担忧这件事？" src="../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="../../../20220128/olympic-sponsors-china-beijing/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“中国是个例外”：为何国际赞助商不愿抵制北京冬奥会</h4><img alt="“中国是个例外”：为何国际赞助商不愿抵制北京冬奥会" src="../../../../../static01.nyt.com/images/2022/01/26/world/OLYMPIC-SPONSORS-01/OLYMPIC-SPONSORS-01-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭</h4><img alt="“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭" src="../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悦世界：一届展现习近平全面愿景的冬奥会</h4><img alt="不再取悦世界：一届展现习近平全面愿景的冬奥会" src="../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="/d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="/d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20210108/china-coronavirus-vaccine-sinovac/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:09:13 GMT -->
</html>